BCGene

BCGene catalogs and annotates 1,421 human genes implicated in brain cancer to support subtype-specific genetic analysis, pathway identification, and candidate prioritization.

Key Features:

• Extensive Gene Collection: 1,421 unique human genes compiled from an exhaustive manual review of over 6,000 PubMed abstracts.
• Annotated Genes for Enhanced Analysis: Curated annotations support biological pathway identification, genomic comparisons across different cancers, and differential expression analysis within anatomical brain regions.
• Subtype-Specific Genetic Insights: Comparative analysis across subtypes reveals genetic events with high mutational frequencies unique to each brain cancer subtype.
• Gene Prioritization and Survival Correlation: A gene prioritization system ranks curated genes, with top-ranked genes significantly associated with survival in a dataset of over 2,000 brain cancer cases.

Scientific Applications:

• Comparative Genetic Studies: Enables cross-subtype and cross-cancer genomic comparisons to identify subtype-specific genetic alterations.
• Pathway and Expression Analysis: Facilitates identification of biological pathways and differential expression patterns across anatomical regions of the brain.
• Candidate Gene Prioritization: Supports prioritizing genes for experimental validation and therapeutic target selection based on ranking and survival associations.

Methodology:

Systematic literature curation and cross-validation of curated gene associations.